Search

everythinglearnresearchcommunity

for

Search:↓

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Certain gene variations might be linked to severe acne in women but not in men.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Black-tailed deer have four types of pelages and molt twice a year.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Finasteride-loaded microemulsions can effectively enhance skin delivery for treating hair loss.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.